Welcome to our dedicated page for Celestica SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Celestica Inc. filings document operating results, governance actions, capital-structure matters, and shareholder communications for a Canadian issuer with common shares registered under CLS on the New York Stock Exchange.
Recent disclosures include Form 8-K reports for quarterly and annual financial results, Regulation FD communications, board and committee transitions, annual meeting records, material-event reporting, and share repurchase authorization. The definitive proxy statement covers director elections, executive compensation, shareholder voting procedures, governance policies, and related proxy matters for Celestica’s public-company oversight.
Celestica Inc. will hold its 2026 Annual Meeting of Shareholders on May 19, 2026, at 9:30 a.m. EDT in a hybrid format, combining in-person and remote participation, with detailed logistics to be provided in its upcoming definitive proxy statement.
The company set March 27, 2026 as the record date to determine which shareholders may receive notice of, and vote at, the meeting. Under its Advance Notice By-Law, shareholders who wish to nominate directors must deliver a compliant notice to the Corporate Secretary by the close of business on April 9, 2026.
Celestica director Luis A. Muller reported an equity award of 37 restricted share units (RSUs) on January 28, 2026. Each RSU represents a right to receive one common share or an equivalent cash amount, and these RSUs vest upon his retirement on that same date.
Celestica Inc. filed a current report to let investors know it has released its financial results for the quarter and full year ended December 31, 2025. The company issued a press release on January 28, 2026 and plans to hold a conference call on January 29, 2026 to discuss these results.
The press release is attached as Exhibit 99.1 and is furnished rather than filed, meaning it is not automatically subject to certain Exchange Act liabilities or incorporated into other securities filings unless specifically referenced.
BlackRock, Inc. has filed a Schedule 13G reporting a passive ownership stake in Celestica Inc. common stock. BlackRock reports beneficial ownership of 6,319,910 shares, representing 5.5 % of Celestica’s outstanding common shares as of the event date 12/31/2025. It has sole voting power over 5,889,304 shares and sole dispositive power over 6,319,910 shares, with no shared voting or dispositive power. The filing notes this ownership reflects certain BlackRock business units and that various underlying clients have rights to dividends or sale proceeds, with no single client holding more than five percent of the total outstanding common shares. BlackRock certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Celestica.
Celestica Inc. reported that one of its directors acquired additional equity-linked compensation in the form of director share units. On 12/31/2025, the director received 237 director share units, recorded as an acquisition with a price of $0 per unit. According to the filing, each director share unit represents a contingent right to receive one common share or an equivalent value in cash, at the company’s discretion, when the holder ceases to serve Celestica as a director, consultant or other service provider.
Following this transaction, the director beneficially owns 444 derivative securities related to Celestica common shares, held in direct form. The disclosure highlights how the director’s economic exposure to the company’s equity is structured through these deferred units rather than immediate share ownership.
Celestica Inc. reported a routine insider equity award for one of its directors. On 12/31/2025, the director received 237 director share units, which are a type of derivative security tied to Celestica common shares. These units were granted at a price of $0 and increase the director’s holdings to 992 derivative securities after the transaction.
Each director share unit represents a contingent right to receive one Celestica common share, or an equivalent cash amount, at the company’s discretion when the holder stops serving as a director, consultant, or other service provider. The filing indicates the director’s ownership is held directly and reflects standard equity-based compensation rather than an open‑market purchase or sale.
Celestica Inc. director reports acquisition of additional director share units. A board member of Celestica Inc. (CLS) filed a Form 4 disclosing that on 12/31/2025 they acquired 267 director share units. These units carry no exercise price and represent the right to receive an equal number of common shares, or an equivalent cash amount, when the holder stops serving Celestica as a director, consultant or other service provider, at the company’s discretion. Following this transaction, the reporting person beneficially owns 1,116 derivative securities (director share units) on a direct basis.
Celestica Inc. reported an insider equity award for one of its directors. On 12/31/2025, the director acquired 170 director share units at a price of $0, reported as a derivative security. After this transaction, the director beneficially owned 170 director share units on a direct basis. Each director share unit represents a contingent right to receive one common share of Celestica, or an equivalent value in cash at the company’s discretion, when the holder ceases to serve the issuer as a director, consultant, or other service provider.
Celestica IncDecember 31, 2025, the reporting person was granted 237 restricted share units (RSUs), each representing a contingent right to receive one common share or an equivalent cash amount at the holder's election. The RSUs were reported as derivative securities beneficially owned in direct form.
The award vests over time, with one-third of the 237 RSUs vesting annually over three years on the anniversary of the grant date. This type of grant is a standard form of non-cash compensation that aligns a director’s interests with those of shareholders by linking part of their compensation to the company’s share performance.
Celestica Inc. reported an equity compensation transaction by one of its directors on a Form 4. On 12/31/2025, the director acquired 127 director share units, listed as derivative securities with a price of $0, reflecting a grant rather than an open-market purchase.
After this transaction, the director beneficially owns 531 director share units, held directly. According to the disclosure, each director share unit represents a contingent right to receive one common share of Celestica or an equivalent value in cash, at the company’s discretion, when the holder stops serving as a director, consultant or other service provider. This filing highlights ongoing alignment of director compensation with shareholder interests through share-based awards.